Having trouble accessing articles? Reset your cache.

FDA approves Roche's Ocrevus for MS

FDA approved Ocrevus ocrelizumab from the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY)

Read the full 130 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE